Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

Merck presents positive phase 3 results for Keytruda regimen in early-stage breast cancer

Approximately 56,800 new cases of breast cancer are diagnosed in the UK every year

- PMLiVE

Innovation and flexibility in long-term follow-up studies

By Harpreet Gill

- PMLiVE

Realizing the Potential of Virtual Patient Simulation With Real-World Outcomes

We're celebrating Healthcare Simulation Week 2024 by highlighting the transformative power of our multi-award-winning medical simulation programs, which have proven impact in delivering significant improvements in clinical skills and outcomes....

Medscape Education

- PMLiVE

Reaching Young Professionals at HFSA ASM 2024

HFSA will kick off at the end of September, and Medscape is proud to support the careers of young clinicians through the sponsorship of the Professionals in Training Lounge. “Providing...

Medscape Education

- PMLiVE

Evolving market access pathways for AI-enabled Medtech in Europe

Louise Maddison (Senior Consultant – Global Market Access, Mtech Access) explores the evolving market access landscape for AI-enabled Medtech, with a particular focus on the key European markets of France,...

Petauri Evidence

- PMLiVE

Roche’s injectable Ocrevus Zunovo granted FDA approval to treat relapsing and primary MS

The subcutaneous formulation has the same twice-yearly dosing schedule as the previously approved intravenous infusion

- PMLiVE

AstraZeneca shares ‘unprecedented’ survival results for Imfinzi/Imjudo regimen in liver cancer

Almost 900,000 new cases of liver cancer are diagnosed globally every year

- PMLiVE

Sanofi/Regeneron’s Dupixent receives FDA approval for adolescents with CRSwNP

Approximately 9,000 adolescents in the US are living with inadequately controlled cases of the chronic disease

- PMLiVE

Omnichannel – beyond MPUs and emails

By Paul Berressem

- PMLiVE

How to boost clinical trial access and make patients health-empowered

Clinical research is becoming more patient-centric, but there's still more that needs to be done to make clinical trials available to everyone. This could include wider participation.

Cuttsy + Cuttsy

- PMLiVE

Medscape Education and Comprehensive Medical Mentoring Program Partner to Empower the Next Generation in Dermatology

In a significant stride toward fostering diversity and inclusivity in dermatology, Medscape Education and the Comprehensive Medical Mentoring Program (CMMP) have established a unique alliance to address critical gaps in...

Medscape Education

- PMLiVE

Eli Lilly announces FDA approval for Ebglyss in moderate-to-severe atopic dermatitis

The inflammatory skin condition occurs in 7.3% of adults in the US

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links